Divalproex Sodium

NuCare Pharmaceuticals,Inc.🇺🇸 United States

FDA Page

Effective Date: Feb 12, 2021
Approval ID: 5a314c42-3695-7669-e053-2a91aa0ac67a
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use Divalproex Sodium Delayed Release Tablets safely and effectively. See full prescribing information for Divalproex Sodium Delayed Release Tablets. DIVALPROEX sodium delayed-release tablets, USP for oral use. Initial U.S. Approval: 1983

Quick Stats

Total Products1

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.